Protective Factors and the Pathogenesis of Complications in Diabetes
Endocrine Reviews · 04.03.2024 · 45 (2) · 227-252
DOI: 10.1210/endrev/bnad030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 28.08.2023. Verfasst von Marc Gregory Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Division, Joslin Diabetes Center, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Diabetic Angiopathies, Diabetes Mellitus, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 213-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Chronic complications of diabetes are due to myriad disorders of numerous metabolic pathways that are responsible for most of the morbidity and mortality associated with the disease. Traditionally, diabetes complications are divided into those of microvascular and macrovascular origin. We suggest revising this antiquated classification into diabetes complications of vascular, parenchymal, and hybrid (both vascular and parenchymal) tissue origin, since the profile of diabetes complications ranges from those involving only vascular tissues to those involving mostly parenchymal organs. A major paradigm shift has occurred in recent years regarding the pathogenesis of diabetes complications, in which the focus has shifted from studies on risks to those on the interplay between risk and protective factors. While risk factors are clearly important for the development of chronic complications in diabetes, recent studies have established that protective factors are equally significant in modulating the development and severity of diabetes complications. These protective responses may help explain the differential severity of complications, and even the lack of pathologies, in some tissues. Nevertheless, despite the growing number of studies on this field, comprehensive reviews on protective factors and their mechanisms of action are not available. This review thus focused on the clinical, biochemical, and molecular mechanisms that support the idea of endogenous protective factors, and their roles in the initiation and progression of chronic complications in diabetes. In addition, this review also aimed to identify the main needs of this field for future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
- Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
- Department of Nephrology, University of Helsinki and Helsinki University Central Hospital, Stenbäckinkatu 9, FI-00029 Helsinki, Finland.
- Minerva Foundation Institute for Medical Research, Tukholmankatu 8, 00290 Helsinki, Finland.
ORCID-Profile: Marc Gregory Yu, Daniel Gordin, George Liang King
Förderung
- NIDDK NIH HHS
Zitieren
APA
Yu, M. G., Gordin, D., Fu, J., Park, K., Li, Q., & King, G. L. (2024). Protective Factors and the Pathogenesis of Complications in Diabetes. Endocrine Reviews, 45(2), 227-252. https://doi.org/10.1210/endrev/bnad030
Vancouver
Yu MG, Gordin D, Fu J, Park K, Li Q, King GL. Protective Factors and the Pathogenesis of Complications in Diabetes. Endocrine Reviews. 2024;45(2):227-252. doi:10.1210/endrev/bnad030
BibTeX
@article{Yu2024,
author = {Yu, Marc Gregory and Gordin, Daniel and Fu, Jialin and Park, Kyoungmin and Li, Qian and King, George Liang},
title = {Protective Factors and the Pathogenesis of Complications in Diabetes},
journal = {Endocrine Reviews},
year = {2024},
volume = {45},
number = {2},
pages = {227--252},
doi = {10.1210/endrev/bnad030}
}
EUVIMED